Clinical Trials Browser

Phase 1/2 × Amyloidosis × Calcium Dobesilate × Clear all

NCT01864018 2025-07-24

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

Phase 1/2 Completed

87 enrolled 13 charts

Amyloidosis, Multiple Myeloma

NCT05486481 2025-03-06

Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)

Phase 1/2 Withdrawn

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT02545907 2021-04-15

CATALYST

Phase 1/2 Completed

10 enrolled 14 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis